I2o Therapeutics Patents – Insights & Stats (Updated 2023)

I2o Therapeutics has a total of 63 patents globally, out of which 1 has been granted. Of these 63 patents, more than 98% patents are active. Europe is where I2o Therapeutics has filed the maximum number of patents, followed by China, Mexico, Australia and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of I2o Therapeutics.

I2o Therapeutics was founded in 2019. I2o Therapeutics is a biotech enterprise. The business creates a platform for biological medications that are typically administered via injection. The goal of I2o Therapeutics is to develop protein- and peptide-based oral medicines. Customers in the US are served by I2o Therapeutics.

Do read about some of the most popular patents of I2o Therapeutics which have been covered by us in this article and also you can find I2o Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over I2o Therapeutics patent portfolio.

How many patents does I2o Therapeutics have?

I2o Therapeutics has a total of 63 patents globally. These patents belong to 12 unique patent families. Out of 63 patents, 62 patents are active.

How Many Patents did I2o Therapeutics File Every Year?

I2o Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantI2o Therapeutics Applications FiledI2o Therapeutics Patents Granted

How many I2o Therapeutics patents are Alive/Dead?

Worldwide Patents

I2o Therapeutics Patent Portfolio

How Many Patents did I2o Therapeutics File in Different Countries?

I2o Therapeutics Worldwide Patent Filing

Countries in which I2o Therapeutics Filed Patents

South Africa5
New Zealand4
Hong Kong (S.A.R.)3
United States of America2

Where are Research Centers of I2o Therapeutics Patents Located?

The Research Center for I2o Therapeutics is the United States of America.

Best I2o Therapeutics Patent

EP3733694A1 is the most popular patent in the I2o Therapeutics portfolio. It has received 20 citations so far from companies like Intarcia Therapeutics, Eli Lilly and Zhejiang Heze Pharmaceutical Technology.

What are I2o Therapeutics key innovation segments?

What Technologies are Covered by I2o Therapeutics?

The chart below distributes patents filed by I2o Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where I2o Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has I2o Therapeutics search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by I2o Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.